Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Oct;10(7):1325-30.
doi: 10.1111/j.1526-4637.2009.00720.x.

A clinical trial of gene therapy for chronic pain

Affiliations
Review

A clinical trial of gene therapy for chronic pain

Darren Wolfe et al. Pain Med. 2009 Oct.

Abstract

The first human trial of gene therapy for chronic pain, a phase 1 study of a nonreplicating herpes simplex virus (HSV)-based vector engineered to express preproenkephalin in patients with intractable pain from cancer, began enrolling subjects in December 2008. In this article, we describe the rationale underlying this potential approach to treatment of pain, the preclinical animal data in support of this approach, the design of the study, and studies with additional HSV-based vectors that may be used to develop treatment for other types of pain.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Schug S, Gandham N. Opioids: Clinical Use. In: McMahon SB, Koltzenburg M, editors. Textbood of Pain. Elsevier; 2006. pp. 443–458.
    1. Dickenson AH, Kieffer BL. Opiates: Basic Mechanisms. In: McMahon SB, Koltzenburg M, editors. Textbook of Pain. Elsevier; 2006.
    1. Mata M, Hao S, Fink DJ. Applications of gene therapy to the treatment of chronic pain. Curr Gene Ther. 2008;8:42–48. - PMC - PubMed
    1. Roizman B, Knipe DM. Herpes Simplex Viruses and Their Replication. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 2399–2460.
    1. Wolfe D, Goins WF, Yamada M, Moriuchi S, Krisky DM, Oligino TJ, et al. Engineering herpes simplex virus vectors for CNS applications. Exp Neurol. 1999;159:34–46. - PubMed

Publication types